Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Elevance Health, Inc. Director's Dealing 2015

Apr 15, 2015

29933_dirs_2015-04-15_3c418434-f56b-48b5-9acb-8614fae873bf.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Anthem, Inc. (ANTM)
CIK: 0001156039
Period of Report: 2015-04-13

Reporting Person: NUSSBAUM SAMUEL R MD (EVP & Chief Medical Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-04-13 Common Stock M 46667 $76.59 Acquired 157639.51 Direct
2015-04-13 Common Stock M 2673 $30.10 Acquired 160312.51 Direct
2015-04-13 Common Stock S 14508 $154.29 Disposed 145804.51 Direct
2015-04-13 Common Stock S 34832 $155.06 Disposed 110972.51 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-04-13 Employee Stock Option (Right to Buy) $76.59 M 46667 Disposed 2016-03-01 Common Stock (46667) Direct
2015-04-13 Employee Stock Option (Right to Buy) $30.10 M 2673 Disposed 2016-03-02 Common Stock (2673) Direct

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2015.

F2: This transaction was executed in multiple trades at prices ranging from $153.78 to $154.72. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected.

F3: This transaction was executed in multiple trades at prices ranging from $154.79 to $155.59. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected.

F4: The option, representing a right to purchase a total of 66,667 shares, became exercisable in five equal semi-annual installments of 11,111 shares each and one semi-annual installment of 11,112 shares beginning on September 1, 2006, which was the six-month anniversary of the date on which the option was granted.

F5: The option, representing a right to purchase a total of 92,285 shares, became exercisable in one semi-annual installment of 15,380 shares and five equal semi-annual installments of 15,381 shares each beginning on September 2, 2009, which was the six-month anniversary of the date on which the option was granted.